NDC 11994-016

Quadramet

Samarium Sm 153 Lexidronam

Quadramet is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Lantheus Medical Imaging, Inc.. The primary component is Samarium Sm-153 Lexidronam Pentasodium.

Product ID11994-016_3f73e214-cad4-4b6d-b1ed-66f1777b57f4
NDC11994-016
Product TypeHuman Prescription Drug
Proprietary NameQuadramet
Generic NameSamarium Sm 153 Lexidronam
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date1997-05-19
Marketing CategoryNDA / NDA
Application NumberNDA020570
Labeler NameLantheus Medical Imaging, Inc.
Substance NameSAMARIUM SM-153 LEXIDRONAM PENTASODIUM
Active Ingredient Strength50 mCi/mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 11994-016-01

3 mL in 1 VIAL, SINGLE-DOSE (11994-016-01)
Marketing Start Date1997-05-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 11994-016-01 [11994001601]

Quadramet INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA020570
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1997-05-19

Drug Details

Active Ingredients

IngredientStrength
SAMARIUM SM-153 LEXIDRONAM PENTASODIUM50 mCi/mL

OpenFDA Data

SPL SET ID:61e84808-0999-4923-910c-2a480d5f971a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 797657
  • 797659

  • Trademark Results [Quadramet]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    QUADRAMET
    QUADRAMET
    78374967 2897509 Live/Registered
    LANTHEUS MEDICAL IMAGING, INC.
    2004-02-26
    QUADRAMET
    QUADRAMET
    74653588 2046461 Dead/Cancelled
    CYTOGEN Corporation
    1995-03-30

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.